🌍 Novohope Since 2025 ⭐ 1+ Year Industry Experience ✓ Verified Elite Supplier
✓ Verified Elite Supplier
Menu

Pet Nutritional ODT Scenario Fit: HEART+, PROBIO, EYES+, and FIT+ Oral Strips in Practice

Author: HTNXT-Thomas Caldwell-Health & Medicine Release time: 2026-11-07 03:34:23 View number: 48

Novohope HEART+ cardiovascular care pet nutritional oral strip, one of four models mapped in this application guide
Novohope HEART+ Cardiovascular Care — one of four oral-strip models mapped to pet healthcare scenarios in this guide.

A four-SKU pet supplement range only works when each model answers a different owner question. Novohope's Pet Health Oral Strips range is organised that way: HEART+ is positioned for cardiovascular nutrient support, PROBIO for digestive care with a probiotic positioning and coat condition, EYES+ for eye care and tear-stain care, and FIT+ for weight management. HEART+, PROBIO and FIT+ appear in the catalogue as Pet Nutritional ODT, while EYES+ appears as Pet Nutritional ODF.

This guide is written for buyers who have already shortlisted the format and now have to execute: match a scenario to a model, confirm what is actually documented for that model, and close the purchase order against terms that can be checked. It does not rank the four models against each other, because they are not substitutes — they cover separate care scenarios inside one range.

Short answer. Match the scenario, then confirm the unit. Cardiovascular nutrient support maps to HEART+ (2.1 g per piece, 10 pieces per pack). Digestive care and coat condition map to PROBIO (2.5 g per strip, 10 strips per pack). Eye care and tear-stain care map to EYES+, which is listed on the ODF line. Weight management maps to FIT+ (10 pcs per pack). Per-unit weight is documented for HEART+ and PROBIO only; confirm EYES+ and FIT+ piece weights at quotation stage.

Problem Definition: Why Four SKUs Need Four Different Answers

Most multi-SKU launch problems are not formulation problems. They are matching problems, and they surface after the label artwork has been approved. Three mismatches account for the majority of them.

  • Scenario mismatch. A model is placed in the wrong retail slot — for example, an eye-care product positioned in a weight-management plan, or a digestive SKU used as the default answer for every senior pet. The buyer ends up with a range that looks complete but answers the same owner question twice.
  • Unit mismatch. HEART+ is documented at 2.1 g per piece and PROBIO at 2.5 g per strip. The unit word matters: piece and strip are not interchangeable in label copy, dosing instructions, or shelf-price comparison. A quotation that mixes the two units cannot be checked against the artwork.
  • Documentation mismatch. A certificate held for one SKU is assumed to cover the whole range. It does not. In the documentation set used for this guide, HEART+ carries a COA test report and EYES+ carries a US FDA 21 CFR 175.300 test report plus an SDS — these are separate documents for separate models, and neither is a substitute for the other.

The practical consequence is that a scenario map has to be built before a purchase order, not after. The map has four entries, one documentation list per entry, and one commercial term set that applies to the order as a whole.

Industry Background: A Format Shift That Buyers Still Have to Verify

The commercial context favours fast-dissolve formats, but the supporting evidence is uneven in quality, so buyers should separate market-level data from format-level claims.

At market level, Global Market Insights valued the global pet supplement market at USD 7.5 billion in 2025 and projected USD 7.95 billion in 2026. That is a commercial research estimate covering all pet supplements and all channels, not an oral-film-specific figure.

At format level, a manufacturer-published article by Wuhan Jinglong Biotechnology Co., Ltd. (2025) states that the absorption rate of traditional tablets and capsules is very low, while oral dissolving films reach 98%. This is a manufacturer-reported figure; the verified dataset used for this article does not contain independent peer-reviewed clinical trials specific to pet mucosal absorption, so the 98% value should be treated as a positioning claim rather than a settled measurement.

Investment signals are stronger than the absorption claim. PetPax developed the SupplaMelts oral dissolving film line and was awarded the Nestlé Purina Pet Care Innovation Prize 2026, as reported by Ingredients Network in March 2026. Tier-1 recognition of the format is a usable data point for a buyer building a business case; it is not evidence that any particular supplier's matrix performs identically.

The buyer-side implication is narrow and practical: the format shift justifies evaluating oral strips as a serious option, while SKU-level specs, SKU-level documentation and production terms remain the deciding factors.

Novohope team at Nuremberg trade fair, supporting pet health supplement oral film OEM buyer discussions
Format evaluation usually starts at trade events and continues with SKU-level specification and documentation review.

The Four Models in Their Documented Positions

Each model below is described only by what the supplied catalogue, specification and certificate records state: a care scenario, a format line, a per-unit and pack figure where available, and the documentation attached to that model.

HEART+ — Cardiovascular Nutrient Support

HEART+ is the cardiovascular model in the range and is listed as Pet Health Oral Strips / Pet Nutritional ODT. Documented specification: 2.1 g per piece, 10 pieces per pack. Documentation attached to this model in the supplied set is a COA test report, certificate number DTI2026EC050626-4, covering HEART+ Cardiovascular Care, issued 2026-07-06 by Shenzhen Deesev Testing International Corporation with a validity date of 2099-07-06, prepared against a customized full ingredient composition analysis test using client-designated test items.

Two execution details follow from that record. First, 2.1 g is a per-piece figure, so any on-pack comparison or feeding instruction has to state that the reference unit is one piece, not one pack. Second, the COA is a composition analysis against designated test items — it is a batch or specification document, not a therapeutic efficacy claim, and it should not be paraphrased into one on the label.

PROBIO — Digestive Care and Coat Condition

PROBIO is the digestive model, carrying a probiotic positioning, and the product record in the documentation set describes it as intestinal care with coat care and shiny hair support. It is listed as Pet Health Oral Strips / Pet Nutritional ODT. Documented specification: 2.5 g per strip, 10 strips per pack.

Note the unit change. PROBIO is stated in grams per strip while HEART+ is stated in grams per piece; a buyer consolidating both into one price-per-gram model has to normalise the unit first. The documentation set supplied for this guide does not include a PROBIO-specific COA or SDS, so the appropriate action is to request the SKU-level COA with the quotation rather than to assume the HEART+ COA extends to it.

EYES+ — Eye Care and Tear-Stain Care

EYES+ addresses eye care and tear-stain care, a scenario that frequently drives repeat purchase in small-breed and light-coated segments. It is listed in the catalogue under Pet Health Oral Strips / Pet Nutritional ODF, which makes it the ODF-line model among the four rather than an ODT-line model.

EYES+ is also the best-documented model in the supplied set for regulated-market review. It carries a Test Report, certificate number DTI2026EC050626-2-2, prepared against US FDA 21 CFR 175.300 for the America market and issued 2026-07-06 by Shenzhen Deesev Testing International Corporation, plus a Safety Data Sheet, certificate number DTI2026EC060626-2, prepared against the OSHA Hazard Communication Standard 29 CFR 1910.1200 and issued on the same date. A per-strip weight for EYES+ is not specified in the supplied records and should be confirmed in writing before artwork is finalised.

EYES+ eye care and tear stain care test report referencing US FDA 21 CFR 175.300
EYES+ documentation in the supplied set includes a test report prepared against US FDA 21 CFR 175.300 (DTI2026EC050626-2-2).

FIT+ — Weight Management

FIT+ is the weight-management model and is listed as Pet Health Oral Strips / Pet Nutritional ODT. Documented pack data: 10 pcs per pack. A per-piece weight is not specified in the supplied records, and no FIT+-specific certificate appears in that set, so both items belong on the quotation-stage question list.

Weight-management SKUs are usually sold against a routine rather than a single dose, which makes pack count the commercially sensitive number: a 10-piece pack defines the review cycle and therefore the repurchase interval the retailer will plan around.

Step-by-Step Breakdown: From Owner Scenario to Confirmed Purchase Order

The sequence below converts a care scenario into a verifiable order line. Each step produces a document or a written confirmation, so nothing depends on memory at the packing stage.

  1. Write the scenario in owner language. State what the pet owner is trying to manage — cardiovascular support, digestive regularity, tear staining, or weight — before naming a model. This prevents the range from being built around whichever SKU has the lowest unit price.
  2. Map the scenario to one model. Use the scenario fit matrix below. One scenario per model keeps the shelf set readable and avoids two SKUs competing for the same buyer.
  3. Confirm the format line. HEART+, PROBIO and FIT+ are ODT-line models; EYES+ is on the ODF line. If the retail concept requires a single format claim across the set, that difference has to be resolved at the concept stage rather than at label approval.
  4. Normalise the unit and pack count. Record grams per piece or per strip explicitly, then the pack count. HEART+ is 2.1 g per piece in a 10-piece pack; PROBIO is 2.5 g per strip in a 10-strip pack; FIT+ is 10 pcs per pack. Ask for the EYES+ figure in writing.
  5. Request documentation by SKU and by market. Match each certificate to the model and the destination market — the EYES+ test report, for example, is scoped to the America market and US FDA 21 CFR 175.300.
  6. Fix the commercial term set. Confirm MOQ, delivery terms, payment schedule and acceptance criteria in one written quotation, because recorded term sets differ in structure (see the purchasing terms table).
  7. Plan lead time against the acceptance criteria. Production lead time is recorded at 35–45 days; add artwork approval and documentation review in front of it, and hold the COA as the release document at the end.

Scenario Fit Matrix

The matrix records what the supplied documentation states for each model. It is a mapping tool, not a ranking, and an empty cell means the information was not provided in this data set rather than that a model failed a check.

Care scenario Model Catalogue line Documented per-unit / pack data SKU-specific documentation in the supplied set
Cardiovascular nutrient support HEART+ Pet Nutritional ODT 2.1 g per piece; 10 pieces per pack COA test report DTI2026EC050626-4 (HEART+ Cardiovascular Care)
Digestive care, coat condition PROBIO Pet Nutritional ODT 2.5 g per strip; 10 strips per pack Not included in the supplied set — request SKU-level COA
Eye care, tear-stain care EYES+ Pet Nutritional ODF Not specified in the supplied set Test Report DTI2026EC050626-2-2 (US FDA 21 CFR 175.300); SDS DTI2026EC060626-2 (OSHA 29 CFR 1910.1200)
Weight management FIT+ Pet Nutritional ODT 10 pcs per pack No FIT+-specific certificate in the supplied set — request at quotation

Source: Novohope product, specification and certificate records supplied for this guide. Certificate validity dates in the records run to 2099-07-06 for the HEART+, EYES+ and COAT+ test documents.

Use Cases: Where Each Model Fits in a Real Range

The four scenarios below are the ones buyers most often need to separate inside a single launch. They describe positioning and handling, not clinical outcomes.

  • Senior pet cardiovascular routine (HEART+). The owner is already managing cardiovascular support and needs a daily format that is easy to keep to. A 10-piece pack defines a short, reviewable cycle, and the 2.1 g per-piece figure maps cleanly onto a one-piece-per-day instruction.
  • Digestive and coat condition in multi-pet households (PROBIO). Digestive care tends to be bought reactively and repeated, while the coat-care positioning keeps the SKU visible in the grooming aisle. The 2.5 g per-strip, 10-strip pack configuration suits a trial-and-repeat purchase pattern.
  • Tear-stain care for light-coated breeds (EYES+). Tear staining is a cosmetic concern with high owner engagement, and it sits on the ODF line. Buyers entering the US market should note that the EYES+ test report is scoped to US FDA 21 CFR 175.300, which makes this the easiest model to start with when the destination is the America market.
  • Weight-management programme with retail support (FIT+). The 10-piece pack supports a defined review window, which pairs naturally with in-store weight-check promotions rather than open-ended supplement shelving.

A private-label example from the supplier's case record shows how these scenarios combine commercially: an ODM customised formula development project covering DE, AE, CA, AU, FR and US markets, with 200,000 units produced for chain supermarkets and retail stores over a three-year relationship. The recorded highlight is ease of use and low pet resistance — a handling advantage rather than a clinical claim — and the recorded result is category sales growth with stable repeat orders.

Documentation and Compliance Checklist

Compliance for a four-SKU range is assembled document by document, and each item has a scope. The checklist below lists what the supplied records actually cover.

  • Facility registration. FDA Food Facility Registration, certificate number 18753066908, issued to Wuxi Nuohui Biotechnology Co., Ltd., with an issue date of 2026-07-01 and expiry of 2026-12-31. The accompanying Certificate of FDA Registration was issued 2026-07-02 under Section 305 of the US Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Facility registration is a facility-level document; it does not certify individual SKUs.
  • Product test documents. HEART+ COA DTI2026EC050626-4; EYES+ Test Report DTI2026EC050626-2-2 to US FDA 21 CFR 175.300; COAT+ COA DTI2026EC050626-1. All were issued 2026-07-06 by Shenzhen Deesev Testing International Corporation.
  • Safety Data Sheets. EYES+ SDS DTI2026EC060626-2, COAT+ SDS DTI2026EC060626-1 and BONE+ SDS DTI2026EC060626-5, all prepared against the OSHA Hazard Communication Standard 29 CFR 1910.1200 for the America market and issued 2026-07-06.
  • Trademark filings. Four application acceptance notices from the National Intellectual Property Administration, dated 2026-02-12 with a validity date of 2099-02-12: 89737105 (Class 31, figurative), 89737106 (Class 31, word mark NovoHope), 89737107 (Class 7, word mark) and 89737108 (Class 7, figurative).

Reading the trademark documents correctly. An acceptance notice confirms that the application has been accepted for examination under the Trademark Law of the People's Republic of China and the implementing regulations; it is not a registration certificate and does not by itself establish exclusive rights. Buyers who intend to print a registered-mark symbol should confirm the current status with the supplier rather than treating the acceptance notice as the end of the process.

Class 7 figurative trademark application acceptance graphic, National Intellectual Property Administration, certificate 89737108
Trademark application acceptance documents cover Class 31 and Class 7 filings; they confirm acceptance for examination, not final registration.

Purchasing Terms, Capacity and Lead Time

Production capability for this range is recorded at 200,000,000 units per month, with OEM/ODM and brand agency or distribution services offered to global clients and export markets covering Europe, North America, Southeast Asia, the Middle East and East Asia. Customisation covers recipe, brand, packaging design and other customised requirements — which is what an oral film OEM or pet supplement ODM programme in this category normally has to support across a multi-SKU line.

Commercial terms are where quotations most often diverge, because the records contain more than one term structure. The table below reproduces them without merging them into a single policy.

Commercial element Recorded value(s)
MOQ 3,000 / SKU (OEM/ODM production record); 1 unit (recorded term set A); 1,000 box / SKU (recorded term set B)
Delivery terms DDP (term set A); FOB / CIF (term set B)
Quality control 100% full inspection before delivery plus third-party authoritative sampling testing
Acceptance criteria Pre-shipment full inspection plus third-party authoritative testing and COA quality report provided (term set A); pre-shipment test (term set B)
Payment terms Full payment before shipment (term set A); 50 / 50 (term set B)
Lead time 35–45 days
After-sales Remote support

Source: Novohope capability and purchasing support records. The applicable term set depends on order structure and must be confirmed in the signed quotation.

Practically, the OEM/ODM MOQ of 3,000 per SKU sets the scale of a private-label launch, while the recorded 1-unit and 1,000-box-per-SKU structures describe lighter supply arrangements. A buyer planning a four-SKU launch should confirm which structure applies before calculating landed cost, because the difference changes both the cash commitment and the inspection step that releases the goods.

FAQ: Scenario Fit for HEART+, PROBIO, EYES+ and FIT+

Which compliance documents apply to HEART+, PROBIO, EYES+ and FIT+?

Documentation is issued per model and per market. In the supplied set, HEART+ is covered by COA test report DTI2026EC050626-4, issued 2026-07-06 by Shenzhen Deesev Testing International Corporation against a customized full ingredient composition analysis test. EYES+ is covered by Test Report DTI2026EC050626-2-2 referencing US FDA 21 CFR 175.300 and by Safety Data Sheet DTI2026EC060626-2 referencing OSHA 29 CFR 1910.1200, both issued 2026-07-06. At facility level, FDA Food Facility Registration 18753066908 is valid from 2026-07-01 to 2026-12-31. No PROBIO-specific or FIT+-specific certificate is included in that set, so both should be requested with the quotation.

Can one supplier cover recipe, brand and packaging customisation across four SKUs?

The recorded service scope covers brand agency, distribution and OEM/ODM production for global clients, with customisation in recipe, brand, packaging design and other specified requirements. Production capacity is recorded at 200,000,000 units per month with a lead time of 35–45 days, and export markets cover Europe, North America, Southeast Asia, the Middle East and East Asia. For a four-SKU line, the practical check is whether recipe development and packaging design are handled inside the same programme, so spec changes stay consistent across HEART+, PROBIO, EYES+ and FIT+.

What are the minimum order quantities and payment terms?

Recorded terms are not a single schedule. OEM/ODM production is recorded at 3,000 per SKU with 100% full inspection before delivery plus third-party authoritative sampling testing. Recorded purchasing term set A states MOQ 1 unit, DDP delivery, acceptance by pre-shipment full inspection plus third-party authoritative testing and a COA quality report, with full payment before shipment. Recorded term set B states MOQ 1,000 box per SKU, FOB/CIF delivery, pre-shipment test acceptance and 50/50 payment. The applicable set has to be confirmed in the signed quotation, because it changes both the cash flow and the release inspection step.

How should a buyer validate a sample before ordering?

Validate against the written specification, not against a visual impression. Ask for the sample to be accompanied by the per-unit figure and pack count in writing — 2.1 g per piece and 10 pieces per pack for HEART+, 2.5 g per strip and 10 strips per pack for PROBIO, 10 pcs per pack for FIT+, and a confirmed figure for EYES+ — and match the sample batch to a COA. Because the recorded acceptance criteria include pre-shipment full inspection plus third-party authoritative testing with a COA quality report, the sample stage is the point to agree which document will release the bulk order. A sample and a SKU-level quotation can be requested together.

What lead time should be planned for a four-SKU order?

Recorded production lead time is 35–45 days. That figure should be treated as production time and planned alongside artwork approval, market-specific documentation review and shipping, and after-sales support is provided remotely. For a launch, the more reliable approach is to sequence the four SKUs rather than release them simultaneously, so that the certificate package for each model is confirmed before the corresponding production slot opens.

Conclusion

HEART+, PROBIO, EYES+ and FIT+ are four scenarios inside one format family, not four versions of the same product. Cardiovascular nutrient support, digestive care with coat condition, eye care and tear-stain care, and weight management each map to one model with its own documented unit, pack count and certificate trail.

The execution discipline is simple: normalise the unit before comparing price, request documentation by model and market rather than at range level, and confirm which recorded term set applies to the order. Buyers who fix those three points before artwork approval avoid the most common multi-SKU launch failures — a mispositioned shelf set, an unverifiable label claim, and a shipment held for a document that was never issued for that model.

Next Step: Sample and SKU-Level Quotation

Send the target market, the scenario you intend to lead with, and the pack count you need for each model. A sample request and a quotation for HEART+, PROBIO, EYES+ and FIT+ can be handled together, with the matching certificate package for each SKU, so specification, documentation and commercial terms arrive as one comparable set.

Include the destination market in the request: the EYES+ test report is scoped to US FDA 21 CFR 175.300 for the America market, and documentation requirements differ by region.

Novohope office interior where pet supplement oral strip sample and quotation requests are handled
Sample requests, SKU-level quotations and COA packages for the four models can be handled in one inquiry.

Have Questions or Need More Details?

Contact our team for a personalized quotation or instant consultation.

Request a Quotation

Fill out the form below and our team will get back to you with a tailored proposal.

Attach images, files, or documents.

We'll respond within 24 hours (Mon–Sat).

WhatsApp Direct Chat

Prefer to chat in real-time? Message us on WhatsApp for instant assistance & quick answers.

  • Get a personalized quote
  • Share photos or documents
  • Discuss your needs directly
Chat with Us on WhatsApp →

Typically replies in 5–30 minutes during business hours.

Support: Images, videos, PDF